64B16-27.620: Disposition of Complimentary or Sample Medicinal Drugs Which Are Unsuitable for Dispensing
PURPOSE AND EFFECT: The Board proposes the rule repeal because the rule language has been moved to Rule 64B16-27.615, F.A.C.
SUMMARY: The rule will be repealed because the rule language has been moved to another rule.
SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS: No Statement of Estimated Regulatory Cost was prepared. The Board determined the proposed rule will not have an impact on small business.
Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
SPECIFIC AUTHORITY: 465.005, 465.022, 499.028 FS.
LAW IMPLEMENTED: 465.022 FS.
IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN FAW.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Rebecca R. Poston, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3253
THE FULL TEXT OF THE PROPOSED RULE IS:
64B16-27.620 Disposition of Complimentary or Sample Medicinal Drugs Which Are Suitable for Dispensing.
Complimentary or sample packages of medicinal drugs which are found to be unsuitable for the purpose of dispensing by reason of physical condition or failure to meet requirements of State or federal law shall be returned to the company of origin in accordance with the requirements of Chapter 499, F.S.
Rulemaking Specific Authority 465.005, 465.022, 499.028 FS. Law Implemented 465.022 FS. History-New 12-26-79, Formerly 21S-15.03, 21S-15.003, 21S-27.620, Amended 11-4-93, Formerly 61F10-27.620, 59X-27.620, Repealed_________.